Michael D Kaufman

USPTO Granted Patents = 47 (Patent Applications = 25)

CIPO Patents = 4 (Patent Applications = 3)

EPO Patents = 10 (Patent Applications = 22)

Average Co-Inventor Count = 3.8

ph-index = 27

Forward Citations = 1,416(Granted Patents)

Location History:

Philadelphia, PA (US) (1998 - 2000)
Lawrence, KS (US) (2010 - 2021)
Waltham, MA (US) (2021 - 2024)

Company Filing History:

42 out of 84

Deciphera Pharmaceuticals, LLC

patents

4 out of 2,595

University of Pennsylvania

patents

2 out of 4,442

Eli Lilly and Company

patents

4. 1 out of 1

Deciphera Pharmaceuticals, Lls

patent

where one patent can have more than one assignee

Years Active: 1998-2025

Loading Chart...

47 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12318374 - Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea (2025-06-03),

2. 12226406 - Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea (2025-02-18),

3. 12213968 - Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea (2025-02-04),

4. 12213967 - Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea (2025-02-04),

5. 12064422 - Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea (2024-08-20),

6. 12023328 - Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea (2024-07-02),

7. 11969415 - (methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea (2024-04-30),

8. 11918564 - Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea (2024-03-05),

9. 11911370 - Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea (2024-02-27),

10. 11903933 - Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea (2024-02-20),

11. 11896585 - Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluorophenyl)-3-phenylurea (2024-02-13),

12. 11850241 - Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea (2023-12-26),

13. 11850240 - Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea (2023-12-26),

14. 11844788 - Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea (2023-12-19),

15. 11801237 - Amorphous kinase inhibitor formulations and methods of use thereof (2023-10-31),

As an AI assistant specialized in innovations, inventions, inventors, patent attorneys, assignees, and patents, I can provide you with a detailed article about the inventor Michael D Kaufman from Lawrence, KS (US), who holds 40 patents.

Title: Unveiling the Inventor Extraordinaire: Michael D Kaufman

Introduction:

Meet Michael D Kaufman, a prolific inventor hailing from Lawrence, KS, who has made significant contributions to the field of pharmaceuticals and biotechnology through his groundbreaking innovations.

Latest Patents:

Among his impressive portfolio of 40 patents, Michael D Kaufman's latest inventions center around the development of compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea. These compositions have shown promise in treating disorders related to the activity of the c-KIT and PDGFRα kinases, including their oncogenic forms.

Career Highlights:

Having worked with esteemed organizations such as Deciphera Pharmaceuticals, LLC and the University of Pennsylvania, Michael D Kaufman has honed his skills and expertise in the pharmaceutical industry. His innovative spirit and dedication to advancing medical treatments have led to the successful development of multiple patented inventions.

Collaborations:

Throughout his career, Michael D Kaufman has collaborated closely with talented individuals in the industry, including coworkers Daniel L Flynn and Scott Bone. Together, they have synergized their skills to drive innovation and bring transformative solutions to the forefront of medical research.

Conclusion:

In conclusion, Michael D Kaufman stands as a true visionary in the realm of pharmaceutical inventions, with his inventive prowess and deep understanding of biochemistry paving the way for revolutionary treatments. His patents serve as a testament to his unwavering commitment to advancing healthcare and improving the lives of many.

If you need more information or have any specific requests, feel free to ask!

This text is generated by artificial intelligence and may not be accurate.